A sudden loss of net worth in middle or older age is associated with a significantly higher risk of death, according to a new study.
A recent trend of using hospital volume as a surrogate measure of cardiovascular care may not accurately represent quality, according to a recent study published in Circulation.
A new study has found that obese patients with metastatic melanoma live significantly longer than those with a normal body mass index — especially male patients treated with targeted or immune therapy.
A new study demonstrates how physicians can use genetic profiling of joint tissue to see which drugs will work for which patients.
Physicians and scientists in the Lurie Cancer Center’s OncoSET program are teaming up to help pioneer precision oncology.
A new, shorter drug regimen to treat certain types of Hepatitis C was found to be as effective as the current, longer treatment, according to the findings of a large multi-center trial published in the New England Journal of Medicine.
Scientists have developed software that can forecast the survival of patients diagnosed with glioma that is more accurate than physicians’ predictions.
A new Northwestern Medicine study has discovered coffee changes many more metabolites in the blood than previously known, including those in the endocannabinoid system.
Maha Hussain, MD, recently published several papers detailing new findings in metastatic castration-resistant prostate cancer treatment and prostate cancer screening.
A new study debunks the “obesity paradox,” a counterintuitive finding that people with cardiovascular disease live longer if they are overweight or obese.
Notifications